Table 1.
Patient demographics and characteristics.
| Total (n = 44) | GI symptoms (n = 31) | No GI symptoms (n = 13) | p value | |
|---|---|---|---|---|
| Age (years) | 55.9 (15.1) | 52.9 (14.6) | 63.1 (14.2) | 0.04 |
| Male | 21 (47.7) | 17 (54.8) | 4 (30.8) | 0.19 |
| Race/ethnicity | ||||
| Hispanic | 16 (36.4) | 13 (41.9) | 3 (23.1) | 0.12 |
| African-American | 12 (27.3) | 9 (29.0) | 3 (23.1) | |
| White/Caucasian | 5 (11.4) | 1 (3.2) | 4 (30.8) | |
| Asian | 5 (11.4) | 4 (12.9) | 1 (7.7) | |
| Other | 6 (13.6) | 4 (12.9) | 2 (15.4) | |
| Comorbidities | ||||
| HTN | 31 (70.5) | 22 (71.0) | 9 (69.2) | > 0.99 |
| DM | 19 (43.2) | 14 (45.2) | 5 (38.5) | 0.75 |
| Obesity (BMI > 30) | 22 (50.0) | 14 (45.2) | 8 (61.5) | 0.51 |
| Lung disease | 15 (34.1) | 12 (38.7) | 3 (23.1) | 0.49 |
| Cardiac disease | 16 (36.4) | 9 (29.0) | 7 (53.8) | 0.17 |
| CKD | 13 (29.5) | 9 (29.0) | 4 (30.8) | > 0.99 |
| Chronic liver disease | 4 (9.1) | 3 (9.7) | 1 (7.7) | > 0.99 |
| IBD | 1 (2.3) | 1 (3.2) | 0 (0) | > 0.99 |
| HIV | 4 (9.1) | 2 (6.5) | 2 (15.4) | 0.57 |
| Cancer | 8 (18.2) | 7 (22.6) | 1 (7.7) | 0.40 |
| Pregnant | 1 (2.3) | 0 (0) | 1 (7.7) | 0.30 |
| Prior transplant | 3 (6.8) | 3 (9.7) | 0 (0) | 0.54 |
| Other autoimmune diseases and immunodeficiencies | 5 (11.4) | 4 (12.9) | 1 (7.7) | > 0.99 |
| Severity on admission | ||||
| Mild | 6 (13.6) | 5 (16.1) | 1 (7.7) | 0.60 |
| Moderate | 22 (50.0) | 16 (51.6) | 6 (46.2) | |
| Severe | 16 (36.4) | 10 (32.3) | 6 (46.2) | |
| Peak severity | ||||
| Mild | 6 (13.6) | 5 (16.1) | 1 (7.7) | 0.75 |
| Moderate | 12 (27.3) | 8 (25.8) | 4 (30.8) | |
| Severe | 26 (59.1) | 18 (58.1) | 8 (61.5) | |
The bold values indicate p-value < 0.05.
The absolute number and percentage of the cohort (in parentheses) with each indicated characteristic. For Age, the median value (in years + / − the SD) is given. Statistical comparison of Ages is by Kruskal Wallis test and for other data by Fisher’s exact test.